Neuroimmunology
Browse Articles, recent Forum and News posts, Patient Handouts, External Resources, and Featured Images and Videos concerned with neuroimmunologic disorders.
In the Spotlight
Autoantibodies: disease markersChronic fatigue syndrome
Lyme disease: controversial issues
Multiple sclerosis: clinical aspects
Paraneoplastic syndromes
Quality-of-life scales for neurologic diseases
Demyelinating Disorders
Acute disseminated encephalomyelitisAcute necrotizing hemorrhagic leukoencephalitis
Balo concentric sclerosis
Clinically isolated syndrome
Fatigue in multiple sclerosis
Multiple sclerosis and fertility
Multiple sclerosis: biological differences in children and adults
Multiple sclerosis: neurobehavioral aspects
Multiple sclerosis: neuroimmunology
Neurologic disorders associated with MOG antibodies
Neuromyelitis optica
Optic neuritis
Optical coherence tomography in multiple sclerosis and neurologic disorders
Progressive multifocal leukoencephalopathy
Sleep and multiple sclerosis
Transverse myelitis
Tumefactive demyelinating lesions
Autoimmune Encephalitis & Related CNS Disorders
Anti-IgLON5 diseaseAnti-LGI1 encephalitis
Anti-NMDA receptor encephalitis
Hashimoto encephalopathy
Movement disorders associated with autoimmune encephalitis
Nonparaneoplastic autoimmune cerebellar diseases
Opsoclonus-myoclonus
Stiff-person syndrome
Paraneoplastic Disorders
Lambert-Eaton myasthenic syndromeParaneoplastic cerebellar degeneration
Paraneoplastic limbic encephalitis
Paraneoplastic opsoclonus in adults
Paraneoplastic retinopathy
Paraneoplastic sensory neuronopathy
Inflammatory & Immune-Mediated Neuropathies
Acquired sensory neuronopathiesAcute inflammatory demyelinating polyradiculoneuropathy
Acute pandysautonomia
Autoimmune sensorineural hearing loss
Bell palsy
Chronic inflammatory demyelinating polyradiculoneuropathy
Congenital myasthenic syndromes
Guillain-Barre syndrome in children
Melkersson-Rosenthal syndrome
Miller Fisher syndrome and Bickerstaff brainstem encephalitis: anti-GQ1b antibody syndrome
Motor and multifocal motor neuropathies
Myasthenia gravis
Neuralgic amyotrophy
Neuropathies associated with cryoglobulinemia
POEMS syndrome
Polyneuropathy associated with anti-MAG IgM antibodies
Primary systemic amyloidosis: neurologic complications
Sarcoid neuropathy
Sensory neuropathies associated with anti-GD1b ganglioside antibodies
Localized & Systemic Vasculitis
Eosinophilic granulomatosis with polyangiitisPrimary CNS angiitis
Systemic small-vessel vasculitis
Takayasu arteritis
Temporal arteritis
Vasculitic neuropathies
Disorders Associated with Infectious Diseases
AIDS and HIV: neurologic manifestations and complicationsCongenital cytomegalovirus
Congenital lymphocytic choriomeningitis virus infection
Congenital rubella
HTLV-1 associated myelopathy
Lyme disease: controversial issues
Neuropathies associated with cytomegalovirus infection
Inflammatory & Immune-Mediated Myopathies
DermatomyositisInclusion body myositis
Polymyositis, necrotizing autoimmune myositis, and fasciitis
Viral and retroviral myositis
Related Topics
Behcet diseaseChronic cerebrospinal venous insufficiency
CLIPPERS
Endocrine neuroimmunology
Neurosarcoidosis
PANDAS
Progressive systemic sclerosis
Rheumatoid arthritis: neurologic manifestations
Sjogren syndrome: neurologic complications
Susac syndrome
Systemic lupus erythematosus
Vogt-Koyanagi-Harada syndrome
Treatment Information
AlemtuzumabAzathioprine
Clinical trials in multiple sclerosis
Dalfampridine
Dimethyl fumarate
Fingolimod
Glatiramer acetate
Infliximab
Interferon beta 1a
Interferon beta 1b
Intravenous immune globulin
Mitoxantrone
Multiple sclerosis: management
Multiple sclerosis: treatment of its symptoms
Mycophenolate
Natalizumab
Natalizumab and PML in MS
Ocrelizumab
Pyridostigmine
Vitamin D in neurologic disorders
Forum
Interact with your peers.
News
See what's being published in neurology and the neurosciences.
Oct 30, 2019
Drug is a novel oral fumarate with a distinct chemical structure that is designed to impact its gastrointestinal tolerability.
How to improve multiple sclerosis therapy
Aug 20, 2019
New drugs haven't brought about any significant improvement in the treatment of progressive multiple sclerosis. For a variety of reasons.
Adding multiple sclerosis drug to targeted cancer therapy may improve glioblastoma outcomes
Aug 09, 2019
By reaching stem cells at the tumor's root, multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice.
View AllPatient Handouts
Print or email information for your patients when needed.
Bell palsy
Miastenia gravis (Spanish)
Multiple sclerosis
Multiple sclerosis (condensed)
Myasthenia gravis
Parálisis de Bell (Spanish)
Guidelines
AAN: Assessment and management of psychiatric disorders in individuals with MS
AAN: Clinical Evaluation and Treatment of Transverse Myelitis
AAN: Complementary and alternative medicine in multiple sclerosis
AAN: Efficacy and safety of medical marijuana in selected neurologic disorders
AAN: Efficacy and safety of mitoxantrone (Novantrone) in the teatment of multiple sclerosis
AAN: Immunotherapy for Guillain-Barre syndrome
AAN: Multiple Sclerosis
AAN: Neutralizing antibodies to Interferon-beta: clinical and radiographic Impact
AAN: Plasmapheresis in neurologic disorders
AAN: Thymectomy for autoimmune myasthenia gravis
AAN: Use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis
AAN: Utility of MRI in suspected MS
Other External Resources
Explore other relevant websites.
Featured Images and Videos
Learn from examples.
